There are moments in a company's journey that feel especially meaningful. This is one of them. At the American Association of Neurological Surgeons (AANS), 2026 AANS Annual Scientific Meeting our CEO and co-founder Simon Malpas PhD presented on investigational approaches to home intracranial pressure (ICP) monitoring and what it could mean for ongoing research in hydrocephalus. Hydrocephalus is a condition that does not stay still. Symptoms can change and fluctuate. Yet mu

The results from a first‑in‑human clinical study evaluating the Kitea System have been published in Nature Communic ations, a peer‑reviewed scientific journal. This publication reflects a collaborative effort across Kitea Health, the University of Auckland (Auckland Bioengineering Institute UoA), and hashtag#AucklandCityHospital to advance scientific understanding in the management of hydrocephalus. Led by Professor Simon Malpas and an exceptional multidisciplinary team inclu

Kitea has been busy expanding the knowledge and experience across its team and is excited to welcome Dr Harry Rowland as the new Chair of the Board at Kitea Health. An important step as Kitea continues advancing its breakthrough remote physiological monitoring technology, the Kitea System. Harry brings deep experience in scaling MedTech companies from innovation through clinical validation, regulatory approval, and commercialisation. His experience will be invaluable as Kitea

“As the year comes to a close, I feel incredibly proud of what the Kitea Health team has achieved. This year, we moved into our new facility at Future House Parnell, grew our team, shared our first clinical data around the world, and took major steps forward with regulators in the United States. Our devices continue to perform safely for patients of all ages, and the feedback from surgeons has been deeply encouraging. None of this happens without belief, support, and an amazi

Kitea Health has announced the opening of its new state-of-the-art facility, marking a significant milestone in its commitment to innovation, quality care, and improving the way chronic care is managed. Designed with a strong focus on safety and reliability, the facility operates under ISO 13485 and GMP standards. It has the capacity to produce up to 10,000 Kitea Systems annually, supporting chronic care management while also contributing to the local economy. The company’s m

Nationwide Children’s Hospital and the Hydrocephalus Association are uniting global leaders in a pivotal international event dedicated to advancing hydrocephalus care. Professor Simon Malpas, CEO and co-founder of Kitea Health, has been invited as a panellist in Ohio, USA, and will lend his expertise to this groundbreaking gathering. Backed by the mission of the Hydrocephalus Association to improve the lives of those impacted by the condition, Simon will be sharing how bold i

From quiet research labs to global recognition. Simon Malpas, EY Entrepreneur of the Year finalist. From research fellow to Professor of Physiology to founding not one but three successful medical startups, including ventures that have gone on to be acquired, Simon’s journey is a true reflection of grit, perseverance, and pure brilliance. His work is transforming the way we tackle some of the most complex challenges in health, but just as powerful is the way he builds teams t

We’re proud to share that Kitea Health has been awarded the 2025 Aware – Most Innovative Deep Tech Solution at the NZ Hi-Tech Awards. This honour recognises our pioneering work in implantable sensors that offer real-time monitoring for conditions like hydrocephalus-tools that empower timely, proactive care. But this award means more than recognition. It speaks to a much larger mission. Tackling a Chronic Problem, Boldly Chronic health care management is one of the toughest, m

Jessica Grainger bravely shared her journey on Paddy Gower, TFN, shining a light on the realities of living with a chronic condition, such as Hydrocephalus, and the need for proactive health care management. We’ve had the privilege of working with Jessica as part of the The University of Auckland first-in-human clinical trial at Auckland Hospital. The Kitea Health System has the potential to improve outcomes for patients living with chronic conditions. For families facing the

Kitea Health has been named a finalist in the Aware Group (an HSO Company) Most Innovative Deep Tech Solution category at the prestigious New Zealand Hi-Tech Awards! For those unfamiliar, the Hi-Tech Awards are a cornerstone of the New Zealand technology sector, recognizing and celebrating the very best in innovation and achievement. With hundreds of companies entering each year, simply being selected as a finalist is a significant accomplishment and a testament to the hard w

Kitea Health is pleased to welcome P. (Laxmin) Laxminarain to our Board of Directors. With over 3 decades of leadership experience in Johnson & Johnson including as Worldwide President of Codman Neuro, as well as over 7 years serving on Boards for neuro health and medical technology companies including GT Medical, Microbot Medical, Oculogica and Millar, he brings a wealth of knowledge and strategic expertise. His proven reputation in the medical technology industry as well as

Kitea Health is taking the next step in its growth! It's now live on Snowball, an alternative investment platform, giving people the chance to invest in the MedTech industry and catch an investment opportunity at an early stage company. Learn more on the Kitea Health Snowball investment opportunity, the vision, financial projections, technology, and the market need here.

Kitea Health is celebrating the recognition of its CEO and co-founder, Professor Simon Malpas, as a finalist for the Innovator of the Year award, presented by the Kiwibank, New Zealander of the Year Awards. This acknowledgment signifies the impact of Professor Malpas's extensive work and the innovative approach Kitea Health embodies. The announcment recognition celebrates his decades of groundbreaking research, from the Auckland Bioengineering Institute at the Univerisity of

Kitea Health are thrilled to announce that Kitea has reached another significant milestone in our mission to enhance the lives of individuals with hydrocephalus. Off the back of the FDA Breakthrough Device Designation, we are proud to join the FDA’s exclusive Total Product Life Cycle Advisory (TAP) program. As one of only 65 devices worldwide selected for this program, we will benefit from expedited interactions with the FDA, akin to a breakthrough designation on steroids! Th

Kite Health achieved a major milestone over the weekend by securing Breakthrough Device Designation from the FDA for its innovative pressure monitoring technology. This designation signifies that the FDA recognizes the potential of Kitea's technology to significantly improve the management of chronic health conditions. For Kitea, this breakthrough designation is a game-changer. It accelerates the development and regulatory review process, potentially bringing their life-savi

Across New Zealand, Australia, and the design sector, companies are recognized for the work and products they are producing via the Best Awards. This year, Kitea Health, an innovative company known for it's patient-centric approach, has taken home gold for it's Kitea Health System. Having a recognition from the industry experts and a gold pin approval on it's useability and technology is one Kitea cherish deeply. A big thank you to Designers Institute of New Zealand and Best

Kitea Health, has achieved a significant milestone with co-founder Natalia Lopez securing a spot to represent New Zealand at the prestigious 2024 Startup World Cup. This global competition will take place in Silicon Valley where Natalia will showcase the innovative Kitea System to a panel of over 2,500 investors, Venture Capital firms (including Pegasus Investments), and interact with other promising startups from around the world. The Kitea System, developed by Kitea Health,

KiwiNet Award Category: PwC Breakthrough Project Another recognition, with another opportunity to showcase the amazing work Kitea Health is doing. Kitea Health has been nominated for the prestigious 2024 KiwiNet Research Commercialization Awards. Award Category: PwC Breakthrough Project. The team from Kitea Health has developed a product that can proactively monitor changes in intracranial pressure for patients with hydrocephalus. While shunts are currently used to manage hyd

Kitea Health has been recognized as a finalist in the prestigious 2024 Best Design Awards for Non-Consumable Products. The company's innovative Kitea Health Wand has impressed the judges with its design and potential impact. Designed by Daniel McCormick, Senior Research Fellow at the Auckland Bioengineering Institute and Head of Engineering at Kitea Health, the Wand is a groundbreaking innovation empowering patients with chronic conditions like hydrocephalus to remotely manag

Dr. Simon Malpas, CEO of Kitea Health, recently shared a truly inspiring journey on the See Tomorrow First podcast. His passion for transforming lives through technology is evident as he described the company's groundbreaking, fully implantable device, which is now in clinical trials. Unlike other companies in the field, such as Neuralink, which still rely on external-to-body components tethered systems, Kitea's innovative approach is truly pioneering. Dr. Malpas shared the